# Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

> **NCT01966809** · PHASE2 · TERMINATED · sponsor: **Harry T Whelan, MD** · enrollment: 1 (actual)

## Conditions studied

- Brain Tumor, Recurrent

## Interventions

- **DRUG:** Photofrin photodynamic therapy.

## Key facts

- **NCT ID:** NCT01966809
- **Lead sponsor:** Harry T Whelan, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2017-12-19
- **Final completion:** 2017-12-19
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient enrollment.
- **Last updated:** 2019-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01966809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01966809, "Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01966809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*